story of the week
Routine Re-Screening for Latent TB Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study
J Am Acad Dermatol 2022 May 18;[EPub Ahead of Print], U Khanna, J Gallop, A Ellis, J Hu, A Galadari, A Saklecha, SM Gordon, ME Husni, F Rieder, AP FernandezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.